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1. Introduction 
Biomedical polymers have a wide variety of applications for external and internal use. 
Similar criteria must be fulfilled by biomedical polymeric materials used as internal or 
partly internal (invasive) devices, where the polymer gets in contact with the human 
environment. The material needs to be biocompatible, neutral to the human body and have 
to express excellent stability and resistance against tissues, cells, enzymes and different body 
fluids. The body response to the polymer can be acceptance or rejection and depending on 
the location of the material, these responses are influenced by different factors. Besides the 
body response, the microbiological effect and biofilm formation on the internal medical 
devices are of great importance. If biofilm adheres to the surface it can initiate a degradation 
process of the material, and due to the high concentration of microorganisms, infections and 
health related problems can be caused. The biocompatibility of polymers does not only 
depend on the chemical structure, the capability of microbes and the body environment to 
adhere or also initiate the degradation inside the human body is highly structure dependant. 
Once degradation occurs, along with the migration of additives and low molecular weight 
compounds, the polymer loses its biocompatibility and stability, which can lead to the 
failure of the device or could cause health related issues. Therefore the understanding of the 
different degradation processes that may occur inside the human body due to blood, tissue 
or biofilm interaction is very important. This chapter gives an overview on the mechanism 
of biofilm formation and adherence to surfaces, and means to characterize and determine its 
presence. Furthermore, the effect and the role of body-polymer interaction, the degradation 
mechanisms and the factors influencing the degradation of medical polymers are discussed. 
The factors that should be controlled are the biofilm formation and the prevention of 
infections caused by the microorganisms that usually generate intensive body reactions. 
Means to modify the polymeric materials by incorporating antimicrobial agents into the 
bulk of the polymer or right onto the surface as a coating is presented.  
2. Biofilm 
2.1 Characteristics and formation 
By definition, biofilms are aggregates of microorganisms, which are formed due to the 
attachment of cells to each other and/or to a host surface in an aqueous environment. (Lynch 
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et al., 2003) In general, biofilms can host microorganisms such as bacteria, fungi, protozoa, 
algae and their mixtures, and usually the constituent cells require similar conditions to initiate 
and progress the cell growth. The factors that influence the biofilm formation are humidity, 
temperature, pH of the environment or medium, atmospheric conditions and nutrition 
sources. Besides microorganism cells, biofilms usually contain 80-90% of water and depending 
on the host surface their thickness may vary between 50-100om. 
Biofilm formation starts with the deposition of microorganisms on the surface of the 
material, followed by growth and spreading of the colonies. Microbial colony numbers are 
often very high and the emerging biofilms contain several layers of microorganisms, 
resulting in a highly complex structure (Flemming, 1998). The microbial cells are encased in 
an adhesive matrix produced by the microorganisms of the biofilm, called extracellular 
polymer substance or exopolysaccharide (EPS), which contains proteins, nucleic acids, lipids 
and polysaccharides. (Mayer et al., 1999, Beech, 2004). EPS influences the adhesion to the 
surface and plays an important role in the protection of the biofilm from outer environment. 
Therefore, the biofilms have an improved resistance against toxins, detergents and 
antimicrobial agents. In some cases the resistance of bacterial biofilms against antibiotics can 
be increased up to 1000 fold compared to isolated colonies. 
2.2 Microbial adhesion  
Since biofilm plays a vital role in a wide variety of industrial, environmental and medical 
applications, the understanding of its formation mechanism and factors that influence the 
attachment to surfaces is essential. The environment which surrounds the surface may 
catalyze the biofilm formation; however, the process in most of the cases is similar. 
Fowler and Mckay were the first ones to investigate and describe the dynamic mechanism of 
bacterial adhesion. They took into account the initial physicochemical characteristics of the 
two surfaces that interact (Fowler and Mckay, 1980). The adhesion of the bacterial cell is a 
sequence of dynamic processes which involves characteristic forces, time scales and length 
scales (Denyer et al., 1993, Dickinson et al., 2000). In the first sequence, the cell is transported 
to the surface by gravitational force (sedimentation) and hydrodynamic forces (fluid flow, 
cell motility) where it reaches a diffusive boundary layer (Fig. 1). At this interface diffusion 
is the main driving force and, due to the small size of the cell, Brownian motion plays a vital 
role in the diffusive transport even closer to the surface. In the interval of the diffusive 
boundary layer there is a certain distance where direct interaction takes place between the 
cell surface and the substrate through attractive and repulsive forces (that includes Van der 
Waals and double layer interactions). At this distance the attachment of the cell to the 
surface is reversible since the interactions between both surfaces are weak (Oliveira, 1992). 
Initially both surfaces are negatively charged and therefore the attractive forces to ensure 
the adhesion must overcome an electrostatic repulse ion barrier. 
The interaction range between the cell and the surface is relatively small (<1 micron), 
however, the characteristic length of the stronger irreversible forces is around 5 to several 
hundreds of nanometers. The time scale of the transport process to the surface is flow 
dependent which is on the scale of 5x10-9 cm2/s for a cell having 1 micron in diameter. Once 
the cell has attached to the surface the strength of the attachment is governed by short range 
interactions (<5nm) which involves the resistance to detachment of the particle (irreversible) 
(Dickinson et al., 2000, Oliveira, 1992). These interactions include hydrogen bonding, shorter 
range Van der Waals forces, electrostatic, ionic and dipole interactions (Bos et al., 1999). The  
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Fig. 1. Cell attachment mechanism redrawn from (Dickinson et. al., 2000) 
long, short range forces and electrostatic interactions which play an important role in the 
bacterial attachment are described by the DLVO theory (Derjaguin and Landau, 1941, Verwey 
and Overbeek, 1948). The theory was developed originally to explain the coagulation 
behaviour of charged colloidal particles; however, it could also be applied to explain the 
interaction between a colloidal particle (as a bacterial cell) and a macroscopic surface (Fig.2). 
 
 
Fig. 2. The DLVO theory 
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Type of interaction Interaction forces 
Approximate interaction energy 
(kJ/mol) 
Reversible 
Long range, weak, low 
specificity 
Van der Waals 
Electrostatic 
20-50 
Irreversible 
Short rage, high specificity 
Dipole-dipole 
Dipole-induced 
dipole 
Ion-dipole 
Ionic 
Hydrogen bonds 
Hydrophobic 
40-400 
Table 1. Reversible and irreversible interaction during bacterial attachment(Oliveira, 1992) 
2.3 Biodeterioration of polymeric materials 
Biofilm formation is common on most polymeric materials used in environments with high 
humidity. The nutrition sources necessary for successful colonisation may consist of the 
material itself or a variety of pollutants that end up on the surface of the material. The 
biofilm-polymer interactions depend on several factors which can be evaluated separately 
and in various combinations in authentic artificial environments that mimic the material’s 
end-use conditions(Wallström et al., 2002, Wallström et al., 2005). The characterization of the 
biofilm growth is also essential and is in general conducted by microscopic (i.e. optical, 
scanning electron microscope) methods, however, a few studies showed that the biofilm 
growth can be monitored by fluorescence lidar imaging as well (Bengtsson et al., 2005, 
Wallström and Karlsson, 2004). 
For polymers, biodegradation is usually a complex system, starting with consumption of 
accessible additives and propagating with the decomposition of the matrix (Figure 
3)(Flemming, 1998).Although biofilm formation on some surfaces does not lead to polymer 
biodegradation it can result in the loss of functionality. Through biofouling, the spreading of 
the biofilm over the surface, the original properties of the material such as hydrophobicity may 
be altered. The deterioration of the medical function by clotting and disrupting the flow 
through for example a urinal catheter may cause pain for the patient or result in a serious 
infection. Medical implants are convenient surfaces for microbial growth, both the short-term 
devices (urinary catheters) and the long-term implants (artificial joints). The notorious biofilms 
consisting of various bacterial strains are protected from the attack by the immune system, 
antibiotics and other antimicrobial agents due to difficulties in penetrating into the biofilm. 
Plastic materials usually contain additives, low molecular weight compounds, residues of 
the polymer synthesis as well as shorter chains resulting from the degradation of the 
material, which migrate out of the material and interact with the biofilm. It is known that 
fillers such as polyesters, adiapates, epoxidised fatty acids, oleates, stearates and carbon-
based plasticisers are perfect nutrition sources for microorganisms in the biofilm (Seal and 
Morton, 1986, Flemming, 1998). The most disputed material in biomedical applications is 
poly (vinyl chloride) (PVC), widely used for tubing purposes. During service life, toxic 
phthalate plasticisers tend to migrate out of the material, exposing the patient and providing 
nutrition to a growing biofilm. This leads to a harder and more brittle material, still 
insusceptible to biodegradation but instead sensitive to physical degradation. 
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Fig. 3. Effect of biofilm formation on polymer material surface (redrawn from (Flemming, 
1998) 
Factors influencing the rate of biodegradation are pH, environment, oxygen, salts, redox 
potential and temperature. Salts could be formed by anions which can be final products of 
microbial metabolism and react with cations (Wallström, 2005). An increase in salt 
concentration or significant change in pH highly assists the breakdown of the polymer 
(Sand, 1997). The transformed surface conditions, including the increasing humidity, induce 
the decomposition rate of the material. 
The excretion of enzymes from microorganisms may accelerate material degradation. 
Microorganisms are capable to cause enzymatic degradation of the polymer, this is the main 
biodegradation process for several medical polymers (e.g. polyurethane etc.) (Albertsson 
and Karlsson, 1994, Karlsson and Albertsson, 1998)). It has been reported that many fungi 
develop powerful enzyme systems to degrade highly stable polymers. These enzyme 
systems promote the reduction of peroxides to free radicals. Fungal hyphae can penetrate 
into the polymer, influencing mechanical stability and facilitate water diffusion into the 
material. Hyphal penetration provides mechanical degradation as a complement to chemical 
breakdown. (Flemming, 1998, Wallström et al., 2002, Gu, 2003, Gu et al., 1997) 
The microorganisms in a biofilm may cause a discolouration of the polymer surface, 
through diffusion of lipophilic pigments into the material. These substances do not alter the 
properties of the polymer, but are impossible to remove (Flemming, 1998). The 
discolouration can also be induced by other environmental factors such as oxidation of filler, 
additives or the polymer it self (Wallström, 2005). Another concern during biodegradation is 
the formation of low molecular weight compounds which may cause various odours. In 
biomedical context the main issue is the potential harmful effect such compounds may have 
to the patient.  
2.4 Medical problems caused by biofilm  
Clinical trials on polyurethane tracheostomy tubes and silicone voice prosthesis showed that 
in most of the cases when a medical device is exposed to microorganisms, biofilm formation 
initiates and ultimately causes degradation of the material (Backman et al., 2009, Bjorling et 
al., 2007, Neu et al., 1993). Besides the negative effects of biofilm on polymeric medical 
devices, there is a high risk for emergence of infections. Recent research showed that 
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biofilms are involved in 65% of microbial infections in the body (Potera, 1999), such as 
urinary tract infections, catheter associated and middle-ear infections, formation of dental 
plaque, gingivitis, coating contact lenses, and less common but more lethal processes i.e. 
endocarditis, infections in cystic fibrosis, and infections of permanent indwelling devices 
such as joint prostheses and heart valves (Costerton et al., 1999, Jarett et al., 2002, Potera, 
1999). The body defence against infections is the production of antibodies (lymphocytes), 
however, the immune system is in capable of penetrating the biofilm and destroying the 
cells. Antibiotic therapy is effective only against free floating bacterial cells and the released 
antigen produced by the biofilm (Lynch and Robertson, 2008, Vergara-Irigaray et al., 2009). 
The reasons for biofilm resistance to antibiotic agents are:  
‚ antibiotics are not able to penetrate the full depth of the biofilm and the diffusion of 
antibiotics in EPS is relatively slow  
‚ many antimicrobial agents are incapable of destroying slow growing or not growing 
cells (stationary phase), in addition, some of the cells in the biofilm have a low nutrition 
intake or live in starved state, which render cell survival   
‚ there are differences in cell wall protein between bacteria in biofilm and their free 
floating counterparts, some bacteria in biofilm can survive without dividing which 
makes them resistant to antibiotics that attack dividing cells or breakdown specific cell 
wall types. 
3. Polymeric materials in medical applications 
The biocompatibility of a medical device or implant, i.e. the ability of a material to perform 
without causing a host response, or having toxic or injurious effects, is highly important 
throughout the lifetime of the biomedical application. (Williams, 1999, Dorland, 1980).A 
non-biocompatible implant is rapidly encapsulated by collagen tissues, resulting in failure 
of the desired function of the product. The amount of the tissue growth around the material 
depends on the polarity; non-polar polymers are surrounded by less tissue, than polar ones 
(Akmal and Usmani, 2000). In case of rejection, the body tries to expel the polymer through 
chemical reactions by phagocytic or enzymatic activity (Gebelein, 1985, Akmal and Usmani, 
2000), resulting in the emergence of inflammations. The body response is highly dependent 
on the form (foam, fibre, film), shape, and movement of the implant, as well as the location 
in the body. A smooth, rounded shape gives less interaction and reduces tissue adhesion 
around the material more than a rough-edged shape. Powdered polymers give high tissue 
interactions owing to the large surface area (Akmal and Usmani, 2000). Adsorption of 
various body chemicals (e.g. triglycerides and steroids) by the material can alter polymer 
properties and also lead to degradation (Gebelein, 1985). 
All polymeric materials degrade to some extent when in contact with the human body 
environment. Polymer implants, under normal circumstances, always undergo abrasion and 
stress (Hofmann et al., 2009). Poor long-term properties such as low resistance to wear and 
mechanical stress result in discomfort or pain for the patient, or costly replacement 
operations. The device or implant must be non-harmful during interactions with tissues and 
no toxic substances may be formed or leach out during the implementation of the 
application. Biomedical materials must be non-toxic, non carcinogenic, non-thrombogenic, 
non-inflammatory and non-immunogenic (King and Lyman, 1975, Venkatraman et al., 
2008). Low molecular weight additives and degradation products produce significant tissue 
interactions due to their mobility and solubility in body chemicals. Therefore, polymers that 
518 Biomedical Engineering, Trends in Materials Science
www.intechopen.com
Prevention of Biofilm Associated Infections and Degradation  
of Polymeric Materials used in Biomedical Applications  
 
519 
contain additives, residual monomers and polymerisation catalysts are not suitable for 
implant purposes.  
Many extracorporeal devices have to be biocompatible with blood due to constant blood 
exposure. The surface treatment of the biomedical devices by anticoagulants (e.g. heparin) is 
essential to reduce the probability of clotting the application. Only a few polymeric 
materials have good blood compatibility; hydrogels, polyether urethane ureas, and 
materials made by affixing biologically inactivated natural tissue to the polymer surface 
(Akmal and Usmani, 2000). 
The most commonly used materials for internal medical purposes are polyurethanes, 
polyolefins, silicones, fluoropolymers, vinyl- and acrylic polymers. Polyether type 
polyurethanes are used in a variety of applications (ligament replacements, heart valve 
prostheses, vascular graft prostheses, breast prosthesis, catheter, cannulae etc.) due to the 
materials good biocompatibility, high resistance against hydrolysis and body fluids, 
excellent mechanical properties (high tensile strength, highly elastomeric) and showing a 
low degree of degradation. The application of the polymer is versatile, from foam to film 
and as a bulk material. 
Silicone rubber, a medical elastomer (poly(dimethylsiloxane)), is as prevalent and versatile 
as polyurethanes. The material can be synthesized in very pure form, is highly inert and 
shows excellent chemical resistance (due to the high hydrophobicity). Besides 
poly(dimethylsiloxane), vinyl- and aromatic (phenyl) dimethylsiloxanes are also preferably 
used as a medical polymer due to the superior surface properties (e.g. super 
hydrophobicity). This surface characteristic and the aromatic groups in the structure make 
the silicone rubbers surface less attractive to microorganisms, thus avoiding biofilm 
formation. The silicone rubbers are used in artificial skin, joint replacement, vitreous 
replacement, artificial heart, breast implants, different types of catheters and cannulae.  
Polyolefins (polyethylene, polypropylene), fluoropolymers (teflon etc.) and acrylic polymers 
are mostly used as prosthetic devices. They express high degree of biocompatibility (almost 
totally neutral), excellent chemical resistance and superior mechanical properties. Compared 
to metallic implants the main advantage of polyolefins and fluoropolymers is the low 
friction coefficient and wear resistance due to their self-lubricating characteristic. The main 
medical applications are hip joints, knee implants etc. Acrlylic polymers show even better 
mechanical properties. They are mostly used as dental materials and bone cements to 
anchor artificial joints to the body. Due to the excellent optical properties methacrylates are 
also used in contact lenses.  
Polymers such as poly(vinyl chloride) (PVC), poly(lactic acid) (PLA), polycaprolactone 
(PCL)  and poly(vinyl alcohol) (PVA)have a variety of different medical applications. PVC is 
commonly used for lung bypass sets, catheters and cannulae, tubing for dialysis, 
endotracheal feeding etc. PVC is preferably used since the material is easy to sterilise and 
simple to process into products that do not crack or leak. The main drawback of PVC is the 
necessity of plasticizers, phthalates, for achieving the required mechanical properties, 
softness and flexibility, since the material itself is stiff. The low molecular weight plasticizers 
can be a target for microbial attack and under certain circumstances they migrate out of 
material and cause toxic reactions in the human body. On the other hand, the loss of these 
additives deteriorates the mechanical properties of the material. PLA is used as a 
biodegradable polymer in controlled-drug release systems, resorbable sutures and 
resorbable bone plates. 
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4. Degradation mechanisms of medical polymers 
The human body contains a variety of enzymes and chemicals that may cause degradation 
of the polymer (Williams, 1992, Williams, 1991). Polymers containing ester or amide 
linkages (i.e. polyurethane) are more likely to hydrolyze or oxidize, while polyether type 
polymers are more stable, showing minimal degradation during long-term exposure to 
human body environment. Chain-scissions and/or crosslinking occur in addition to 
hydrolytic degradation (Kaali et al., 2010a). 
As previously discussed, the biofilm attachment to the surface of the polymeric materials plays 
a vital role in the initiation and propagation of the degradation process. The biofilm formation 
is more pronounced for invasive materials, however, implants, after the implantation, are 
rarely exposed to such aggressive biological milieus. Biofilm can also cause immunological 
response (i.e. infections) that changes the surrounding body environment resulting in a 
negative effect on the material properties (Gumargalieva et al., 1982). 
Based on the molecular, chemical and mechanical interactions with the human body 
environment, four types of degradation mechanisms of polymers used in medical 
applications can be distinguished: hydrolysis, oxidation, enzymatic- and physical 
degradation (Lyu and Untereker, 2009). The kinetics of the processes differ, and the key 
factors are the structure of the material and the surrounding environment (Göpferich, 1996). 
Body fluids represent the environment of the given location in the body or liquids 
(enzymes) produced by the body as an immunological response. In this case, the important 
factor in the material degradation is the change of pH of the surrounding environment, 
since some polymers (i.e. polyesters, polyamides) are highly pH sensitive (Göpferich, 1996, 
Williams, 1992). Another significant factor is the water uptake by the material (which is 
highly dependent on the hydrophobicity). The adsorbed water acts as a plasticizer, altering 
the physical properties of the material, swells the polymer, causing dimensional instability 
of the device or implant, and initiates the degradation of the polymer by hydrolysis. 
In general, the degradation of the polymer by hydrolysisoccurs through three stages, 
however, depending on the molecular weight and the type, some polymers undergo only 
one or two stages (Lyu and Untereker, 2009). In the first stage, the polymer adsorbs water 
and becomes saturated in a short period of time, thereafter reactions between the water 
molecules and the polymer chains initiate. At this stage no auto-acceleration occurs since the 
water content of the polymer is constant, the molecular weight is high and the chain-ends 
concentration is low. This is followed by the second stage, where the molecular weight of 
the polymer decreases, increasing the chain-end concentration to a certain level, where auto-
acceleration initiates and catalyzes the degradation process. Due to the increase in the chain-
end concentration, the water adsorption of the polymer increases extending the polymer-
water interactions, resulting in further decrease in the molecular weight. There is a point 
where the molecular weight becomes so low that it becomes soluble in the media. This 
corresponds to stage three. The low molecular weight compounds that form due to the 
reactions dissolve in the media and the molecular weight of the polymer gradually 
decreases until the polymer is completely dissolved. Although the water uptake of medical 
polymers is low (i.e. polyesters 1%), hydrolysis and bond-cleavage in the polymer chain 
result in a material with a decreased molecular weight and increased number of hydrophilic 
chain-ends. The chain-ends may adsorb an increasing amount of water which can further 
catalyze the reaction and lead to the complete breakdown of the material.  
This is the typical degradation mechanism for polyesters, polyamides and polycarbonates, 
however, the hydrolytic degradation of the stable poly(dimethylsiloxane) may also occur 
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during in vivo use (Kaali et al., 2010a, Lukasiak et al., 2003). Recent long-term studies have 
confirmed that silicone tracheostomy tubes undergo hydrolytic degradation during use 
(Kaali et al., 2010a). Tubes, with an exposure time from one to six months, from several 
patients were collected and the analysis by Scanning Electron Microscopy (SEM), Fourier 
Transform Infrared Spectroscopy (FTIR) and Matrix Assisted Laser Desorption/Ionization 
Time of Flight Mass Spectrometry (MALDI  TOF MS) showed degradation of silicone rubber 
after just 1 months exposure. The SEM micrographs clearly showed evidence of the surface 
alteration during the whole exposure period, which was also confirmed by the contact angle 
measurements, where the change in surface hydrophobicity was established.  
 
 
Fig. 4. SEM micrographs of unexposed silicone rubber tracheostomy tubes (a) and exposed 
to human environment for (b) three and (c) six months. (Kaali et al., 2010a) 
The contact angle slightly decreased as a function of time, however, it must be noted that the 
surface of the silicone remained hydrophobic. The evidence of hydrolytic degradation was 
established by MALDI and FTIR. The FTIR analysis showed the formation of –OH groups, 
which may correspond to materials water uptake, however unlikely due to the high 
hydrophobicity of the silicone material. Besides, traces of protein, resulting from the 
attachment of the biofilm during the service life of the material, were also identified from 
the FTIR spectra. The hydrolytic degradation of the material was confirmed by MALDI TOF 
MS. The formation of low molecular weight silicone compounds with hydroxyl groups was 
identified. These compounds were absent in the unexposed samples. The extended results of 
this study showed that the degradation of polymeric materials and the rate of degradation 
within the human body depend on the biotic degradation, on the surrounding body 
environment and also the applied drug treatment. In addition to MALDI TOF MS, Gas 
Chromatography (GC) and High-Performance Liquid Chromatography (HPLC) are widely 
used for determination of low molecular weight compounds, as reported in several studies 
(Haider and Karlsson, 2002, Hillborg et al., 2001, Khabbaz et al., 2000, Flassbeck et al., 2001, 
Flassbeck et al., 2003, Gruemping and Hirner, 1999). 
The oxidative degradation of medical polymers occurs inside the human body and can be 
monitored in simulated environments (Backman et al., 2009, Kaali et al., 2010b). The reaction 
is caused by the peroxides produced by the human body against “non-accepted” implant 
materials, the rejection mechanism (Lyu and Untereker, 2009, Santerre et al., 2005). 
Inflammation takes place at the implantation site, monocytes are migrating to the site and 
the production of macrophages initiates. If rejection is not possible, the body tries to 
encapsulate the material by foreign body giant cells. These cells and macrophages produce 
peroxides in order to try to break down the material to eliminate it from the body (Lyu and 
Untereker, 2009). The oxidation mechanism begins with the increasing number of free 
radicals due to the oxygen adsorbed from the surrounding tissues or blood. The oxygen 
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molecules react with the existing free radicals (Lyu and Untereker, 2009), resulting in an 
accelerated process where each oxygen molecule produces two radicals. The formed free 
radicals are transported to different parts of the polymer chain causing chain scission and 
formation of new chain-ends, one carrying a free radical and the other containing a double 
bond. The double bonded end can react further and form acids, ketones, while the free 
radical end continues the before mentioned process. This reaction propagates until the 
chains become too short for further degradation. The most susceptible medical polymers for 
oxidation are polyolefins, vinyl polymers, polyethers and polyamides. Several authors have 
reported that polyether type polyurethanes are quite stable against hydrolysis without 
exposure to oxidation (Frautschi et al., 1993, Santerre et al., 2005, Wiggins et al., 2001).  The 
oxidative degradation takes place primarily at the ether linkage of the polymer, where the 
peroxide radical attacks the ccarbon of the soft segment. This reaction leads to the formation 
of an ester linkage which is susceptible to hydrolysis. The oxidative degradation of 
polyether urethane is therefore followed by hydrolysis. The polymeric materials that are 
susceptible or less susceptible to certain degradation processes are summarized in Table 2. 
In the human body, materials undergo also enzymatic degradation(Christenson et al., 2006, 
Duguay et al., 1995, Santerre et al., 1995, Santerre et al., 1993). This is also a defensive 
response of the body against implant materials and can be linked to the activity of the 
tissues and cells. Although enzymes are produced for specific interaction, they are capable 
to recognize “unnatural” substrates such as polymers (Santerre et al., 2005). 
In order to interact with the polymer, the enzyme must diffuse into the material either by 
swelling or hydrolysis (Duguay et al., 1995). This is considered to be the primary contact 
between the enzyme and the polymers surface. At this stage the enzyme becomes inactive, 
forming an “enzyme-bond” complex by attaching to an enzymatically susceptible bond (i.e. 
urethane, ester etc.).If this complex is relatively stable, bond scission may occur between the 
interface bonds and the bound enzyme, which results in the formation and release of 
various compounds. 
 
 Susceptible Less susceptible 
Hydrolysis 
Polyanhydride 
Polyorthoester 
Polyketal 
Polyester (aliphatic) 
Polyolefin 
Polyether 
Polysulfone 
PDMS 
Polycarbonate 
Polyimide 
Polyurethane 
Polyester (aromatic) 
Polyamide 
Oxidation 
Polyolefins 
Vinyl polymers 
Polyethers 
Polyamines 
Fluoropolymers 
Polyesters 
Methacrylates 
Silicone 
Polysulfone 
Polyetheretherketone 
Table 2. Polymeric materials susceptible to degradation  
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These compounds then undergo further degradation and cleavage. Two kinds of enzymatic 
degradation can be distinguished, oxidation or hydrolysis of the material, which are based 
on the type of the enzyme produced (Albertsson and Karlsson, 1994). The enzymatic 
systems are highly specific and are able to catalyze degradation of the particular polymer 
chains summarised in Table 3. 
Due to the complexity of the human body, the materials are exposed to most of the 
discussed degradation mechanisms simultaneously. The different degradation factors need 
to be evaluated separately and in various combinations in artificial environments that mimic 
the product’s end-use conditions, in order to predict and understand the property changes 
that will occur in the material during its lifetime. The negative body response to a foreign 
material is the production of peroxides, therefore the most commonly used solvent to 
simulate this oxidative environment is hydrogen peroxide (Christenson et al., 2006, Lyu et 
al., 2008). Different artificial body fluids are used to test the biocompatibility or 
degradability of the material, such as phosphate buffered saline (PBS) which is used to 
mimic the blood plasma, and artificial lysosomal fluid (ALF) and Gamlbe´s solutions for 
simulating more complex systems. ALF solution simulates the enzymes that may initiate the 
breakdown of the polymer while Gamble´s solution represents the environment of the deep 
lungs (Herting et al., 2007, Midander et al., 2007). In a recent study silicone rubber and 
polyester type polyurethane were exposed to both ALF and Gamble´s solution at 37oC (the 
body temperature) for 3 months (Kaali et al., 2010b). During the exposure the formation and 
increasing concentration of low molecular weight compounds in silicone rubber were 
observed. These substances were the same hydrolyzed compounds that were detected 
during the in vivo use of silicone rubber tracheostomy tubes (Kaali et al., 2010a). In addition, 
polyurethane showed chemical property changes due to the exposure to artificial body 
fluids and based on the results it was determined that oxidative degradation took place. 
These results confirmed that artificial body fluids and simulated environments give similar 
results to in vivo experiments and represent good tools for testing new materials that are 
going to be implanted into the patents. In addition the application of in vitro studies reduce 
the costs and experiment time significantly. 
 
Polymer Enzyme 
Polyurethanes 
Cholesterol esterase, xanthine oxidase, 
cathepsin B, collagenase 
Polyglycolic acid Esterase, chymotrypsin, trypsin 
Polyester Esterase 
Polyester urea Urease, pepsin, chymitrypsin 
Polycaprolactone Lipase, carboxytic esterase 
Polyamide 
Polymethylmethacrylate 
Esterase, papain, trypsin, chymotrypsin 
Table 3. Polymers susceptible to enzymatic degradation (Santerre et al., 1995) 
Besides chemical degradation, physical degradation of the polymers also occurs in the 
human body. This is most relevant for implants that are exposed to different mechanical 
forces during their use, and therefore excellent mechanical properties are key requirements. 
These materials are usually knee and hip joints or other kinds of orthopaedic implants. The 
most common failures of these materials are wearing, breaking or cracking and erosion 
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(Göpferich, 1996). These failures may appear together or separately depending on the 
application, however, it is typical that the orthopaedic implants undergo mechanical friction 
which is associated with motion under pressure. Although UHMWPE is a superior material 
for joint purposes, some studies have reported high degree of mechanical degradation on 
hip and knee implants (Brach del Prever et al., 1996, Heisel et al., 2004, Kabo et al., 1993). It 
was also determined that the wear, friction and oxidative properties are better for cross-
linked UMPWE than the conventional one (Heisel et al., 2004, Heisel et al., 2005, Markut-
Kohl et al., 2009) and that during the mechanical wear, oxidative degradation of the 
polyethylene may occur.  
4.1 Effects of sterilization on polymer degradation 
During the manufacture biomedical materials are exposed to microorganisms and other 
substances even in a very pure production environment. Therefore they have to be sterilized 
and well sealed for storage in order to avoid any contamination or microbes that may cause 
infections or health problems right after the implantation. The sterilizationprocedures are 
presentedin Figure 5. 
Dry heat and autoclaving involve high temperature (~120-180oC) and pressure. The 
sterilization process by these methods could take from 3 minutes up to a couple of hours. 
During this exposure the materials may undergo thermal degradation caused by the 
temperature and hot steam that penetrates into the structure of the materials. Therefore 
commonly used sterilization methods for medical materials used in the human body are 
sterilization by either irradiation or gaseous chemicals (ethylene oxide). 
 
 
Fig. 5. Sterilization methods of medical polymers 
There are two types of irradiation sterilization processes; gamma ray and electron beam. 
During gamma sterilization gamma rays are produced from Co66 source and have a high 
penetration capability up to 50 cm into the material. Electron beam sterilization is performed 
by an electron beam generator (1MeV-12MeV), which generates high-energy electrons. The 
penetration depth is around 5 cm, however, compared to gamma rays at the same strength, 
the dosage rate for the electron source is many times greater. This is due to the characteristic 
of the electron beam, which is unidirectional and therefore more concentrated on a smaller 
area, while gamma rays are less focused and cover a bigger surface. Both electron and 
gamma rays have such a high energy that the microorganisms that remain in the material 
after the production are accurately destroyed. From the material point of view these high-
Sterilization 
methods
Dry heat Autoclaving Irradiation
Gamma ray Electron beam
Gaseous 
chemicals
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energy impacts initiate changes in the structure of the material. These changes can be bonds 
scission, cross-linking, branching and degradation of additives. It has been reported that 
polyurethane catheters treated with electron beam sterilization undergo oxidative 
degradation, which leads to chain scissions in the hard and soft segments. This leads to the 
formation of smaller highly volatile soft segment fractions. In addition cross-linking occurs, 
that is thought to be influenced by the chain scissions of the hard segment, and forms on the 
urethane linkage sites. Most of the medical polymers contain additives that can be degraded 
by the electron beam and therefore can be easily released from the polymer. This causes a 
decrease in the stability of the polymer and could cause cytotoxicity (Guignot et al., 2001, 
Mrad et al., 2009a, Mrad et al., 2009b, Ravat et al., 2001a, Ravat et al., 2001b). Gamma 
irradiation has similar influence on the material. Due to the gamma sterilization, branching 
on polyurethanes (Haugen et al., 2007) and an extremely high rate of oxidation was 
observed on UHMWPE implants (Bracco et al., 2006, Goldman et al., 1998). During the 
irradiation, oxygen penetrates into the amorphous region of the polymer where misfit strain 
is developed. As a result the lamellae boundaries become tortuous which leads to further 
strain development and microcracking. Microcracking is a serious problem for materials 
designed for prosthetic purposes since it influences the mechanical properties negatively 
and the lifetime of the material decreases. Besides the types of irradiation, the dosage, flux 
and the outer environment have an effect on the degradation rate and degradation 
mechanisms that occur. For instance, the higher flux and the presence of oxygen increase the 
oxidation, since it generates anincreased formation of free radicals. 
Besides irradiation, the use of gaseous chemicals is also prevalent. For this purpose usually 
ethylene oxide is used which is a strong alkylating agent, toxic and carcinogenic gas. The 
effectiveness of this gas on sterilization depends on the sterilization method which includes 
several factors. These are regarded as the gas concentration, temperature, relative humidity, 
the permeability and absorbance of the polymer. It has been reported that sterilization with 
ethylene oxide has no or very minimal influence on the structure of the polymer (Abraham 
et al., 1997, Burgos and Jiménez, 2009, Gilding et al., 1980, Lucas et al., 2003). However, the 
residues of the gas that remain after the process could at a certain concentration (above 400 
ppm)cause toxicity (Bolt, 2000, MacNeil and Glaser, 1997). In principle the amount of 
remaining residue depends on the applied sterilization method and the polymers 
absorbance. Therefore with a proper method development that suits for the polymer and 
allows the complete release of ethylene oxide is necessary. Among the currently used 
sterilization processes the treatment with ethylene oxide has a big potential compared to 
irradiation techniques due to the reduced risk for degradation and subsequent health 
related issues.  
4.2 Effects of degradation products on the human body 
The degradation of the biomedical materials and formation of the degradation products 
have a serious influence on the human body (Lyu and Untereker, 2009). For instance, due to 
hydrolysis carboxylic acid and/or hydroxyl chain ends may form. Hydroxyl groups can be 
further oxidized and the reaction may produce different kinds of degradation products i.e. 
aldehydes, ketones or carboxylic acids. The degradation rate and its influence on the body 
depend on the size and location of the implant. However, if a biocompatible material starts 
to degrade it loses its stability and from the application point of view causes decreased 
service time. An example for body reaction is the formation of carboxylic acid, which 
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changes the local pH, causing inflammatory response. As an example during the production 
of some polyurethanes, methylene diamine is used, which is a toxic compound. In case 
ofthese kind of toxic precursors biodegradation is not relevant since base monomer usually 
don´t  form due to chemical degradation. However residues of these monomers may remain 
in the material after the production. This is a technological question and the ability of 
human body to handle these kind of compounds depends on several factors i.e. can the 
compound be diluted or transported to organs (i.e. kidney) where it can be further degraded 
or flushed away.  
5. Inhibition of biofilm formation and prevention of related infections 
5.1 Current applications 
The potential risk of biofilm formation is a big problem influencing the degradation of 
invasive materials and may cause health related issues. It has been reported (Kumon et al., 
2001) that patients often face catheter associated infections (CAI). From the patient point of 
view, depending on the type of catheter (central venous, urinary etc.), the infection might be 
lethal. For the hospitals, these infections appear as a cost increase for patient therapy, which 
might be anticipated if the biofilm can be properly removed from the surface of the device 
or the material itself would have antimicrobial effect. Invasive materials that are 
permanently exposed to the human environment (especially tracheostomy tubes) require 
occasional checkups in order to determine the physical condition of the device and the 
biofilm growth on the surface. Usually biofilm formation is quite intensive right after the 
implantation, therefore a proper and regular cleaning is needed to remove the biofilm from 
the surface, reduce the biofilm related infections and the risk of the polymer degradation. If 
the biofilm can be completely removed, the surface will be less susceptible to 
microorganisms than in case where some residues or biofilm cells are remaining on the 
surface. In principle the cleaning procedure of medical devices is performed in two steps. 
The first step is the cleaning of the surface with oxidisers or detergents that weakens the 
physical stability of the biofilm and removes dead cells from the surface. In the second step 
the interaction between the surface and biofilm needs to be broken which can only be done 
by an intensive physical action i.e. brushing, scraping or flushing with high pressure of 
water (Wallström, 2005). Since some biofilm cells attach to the surface through ligands and 
chemical compounds, their removal is not possible without the physical surface damage of 
the material. Therefore in the field of biofilm inhibition, the development and improvement 
of cleaning techniques play only a secondary role. There are some promising methods i.e. 
mucus shaver and different sterilization treatments (argon plasma etc.) for the reduction or 
removal of biofilm after the attachment (Berra et al., 2006, Lee et al., 2009),however, the main 
priority is to inhibit the ability of the biofilm to attach to polymeric surfaces.  
Most of the currently used medical devices that express antimicrobial effect contain either 
biocides or silver. It is known that silver has antimicrobial effect, however, the mechanism is 
not fully understood. Silver ion has the capability to be exchanged by ions that exist in the 
environment (Ca+, Zn+ etc.) and attach to bacterial cells (Schierholz et al., 1998). It forms 
chelate-complexes with the DNA of the bacteria. These complex molecules block the main 
transport processes of the cell, which leads to its decay. The sensitivity of Gram negative 
and  Gram positive strains to silver varies due to the structural differences and is influenced 
by the attachment of silver to murein in the cell wall by adsorption. If it reaches a certain 
concentration in the cell wall it forms the chelate complex with the DNA. By increasing the 
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silver ion concentration the antimicrobial activity can be increased, however, a certain 
concentration in the human environment (10mg/L ,(Schierholz et al., 1998)) is cytotoxic and 
may lead to argyria.   
The antimicrobial efficiency and the performance of antibiotics and silver treated catheters 
against CAI have been compared in several studies (Böswald et al., 1999, Lyu and 
Untereker, 2009, Paterson et al., 1999, Walder et al., 2002). The most commonly used 
antibiotics for treatment of the catheters are minocycline-rifampin, piperacillin, gentamicin, 
and ofloxacin. Silver indifferent forms (ion, compound, hydrogel, metallic) can be used 
inmedical devices. The most common ones for invasive materials are chlorohexidine-silver-
sulfadiazine and impregnated silver. The studies showed that use ofmonociclyne-rifampin, 
ofloxacim and chlorohexidine-silver-sulfadiazine resulted in the least number of CAI 
compared to the other agents. Silver sulfadiazine expressed a high degree of 
biocompatibility and applicability in human environment (Böswald et al., 1999, Paterson et 
al., 1999), however, monocycline-rifampin showed better antiseptic properties. The 
antibacterial mechanism of silver-sulfadiazine is not completely understood. In a trial it was 
shown that in case of central venous catheters (CVC´s), probably the chlorine was 
responsible for the decreased CAI since it secedes from the surface of the polymer easier 
(Schierholz et al., 1998) Impregnated silver was less accurate because the mechanism is 
based on the migration and diffusion. Since silver-sulfadiazine is a salt it dilutes easily from 
the surface while impregnated silver ions must diffuse out in order to get in contact with the 
outer environment. Results of short and long term ion release studies of impregnated silver 
and silver-oxide coated catheters showed that during the first month the release of silver 
ions decreased significantly as a function of time while after four months it remained 
unaltered. During the exposure the impregnated catheter showed better antimicrobial 
results compared to a control sample where, the initial silver release was 2,5 ppm(Kubey et 
al., 1995). The use of hydrogels as antimicrobial agents in the medical industry is exceeding. 
Silver-hydrogels are preferably used as dressings for wound healing (Castellano et al., 2007, 
Ip et al., 2006), however, they show good antiseptic properties as polymer coatings on 
urinary catheters as well (Kwan and Fontecchio, 2002). Besides silver containing coatings, it 
was confirmed that nitrofurazone is also an excellent antibacterial agent that reduces the 
risk of urinary and blood-stream infections (Johnson et al., 2006). 
The different forms of application of silver as an antimicrobial and antiseptic agent for 
invasive materials is promising based on the clinical trials, however, the real efficiency is 
sometimes questionable (Walder et al., 2002). In order to use silver in medical applications, 
the standardization of this material is necessary. This standardization is difficult since the 
effect is influenced by several factors; the destruction of different bacterial strains requires 
different silver concentrations and the minimum inhibitory results may give broad intervals 
of concentration. As an example, the minimum inhibitory concentration (MIC) for 
Stapylococcusaureus and Pseudomonas aeruginosa can vary 8-80mg/L (Chopra, 2007). The 
broad interval depends on the variation of the silver concentrations in different products 
and the variation of the release as a function of time depending on the nature of the material 
(i.e. water absorption) and the physical, chemical form of the silver and the location in the 
material. Moreover, there are bacterial strains that are resistant to silver and this mechanism 
is yet not well understood. There are species that become resistant by the modification of 
gene mutation or identification of the silver as a toxic material when it gets into the cell 
resulting in a rejection mechanism. Besides silver, certain bacterial strain has resistance 
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against specific antibiotics (e.g. MRSA: Methicillin-Resistant Staphylococcus aureus) or in 
extreme cases this resistance can expand to several groups of drugs. 
During the improvement and development of antimicrobial and antiseptic materials that 
inhibit the biofilm formation and infections, these factors must be well considered. 
5.2 Research strategies and trends to decrease device related infections and biofilm 
formation 
There is a variety of developments and improvements in this field, however, the different 
forms and applications of silver or other antibacterial metals give the main direction of the 
research. Silver, copper and titanium nanoparticles are usually used and their in vitro 
antimicrobial efficiency is more or less confirmed, however silver is superior compared to 
other metals. The antimicrobial mechanism of the nanoparticles is not known but it can be 
assumed that it is similar to the ions. This is due to their small size and high specific surface 
area which makes them extremely reactive with the environment. If a nanoparticle interacts 
with a bacteria cell, ions may attach to the cell blocking the main transport phenomena and 
the replication of the DNA. The particles are incorporated into the material by mixing, bulk 
reduction (composite) or by a surface modification procedure (implantation, coating). 
During the production of composites aggregation of the particles takes place.  This is a big 
problem, since the size of the particles increases due to the aggregation, which influences 
the diffusion and the antimicrobial properties (Jeong et al., 2005, Schmidt and Malwitz, 
2003). Besides the size, the shape of the nanoparticles also influences the antimicrobial 
properties. It has been reported that truncated cone shaped particles express better 
efficiency against microbial growth than the spherical ones (Pal et al., 2007). In order to 
reach a homogenous dispersion of the particles by mixing, the use of a surfactant is 
necessary (Dirix et al., 1999). Therefore bulk reduction is a better procedure to prepare 
polymer matrix nanocomposites. In this process, theoretically, the polymer is responsible for 
the stabilization of the nanoparticles. In principle, the first step is the addition of silver in to 
the polymer by mixing a silver compound (i.e. AgNO3) with the polymer solution. As a 
second step, a reduction agent is added to the system and the formation of nanoparticles 
initiates. This change is usually followed by a colour change. The effectiveness of this 
procedure has been confirmed by several studies (Akamatsu et al., 2000, Babu et al., 2006, 
Mahapatra and Karak, 2008, Sambhy et al., 2006). Another perspective of silver-polymer 
composites is the incorporation of silver ions into zeolite which is then mixed into the bulk 
polymer. It is known that zeolite is a natural mineral and has a high ion-exchange capability. 
Research papers confirm high efficiency of Ag-zeolite polymer against microorganisms 
(Kam et al., 2008, Kawahara et al., 2000, Pehlivan et al., 2005, Kaali et al., 2010b). The 
efficiency is based on the silver content which is linked to the zeolite content. The higher the 
zeolite content the better the antimicrobial efficiency. However, zeolite is a hydrophilic 
material and therefore adsorbs moisture and water easily. An in vitro study showed that the 
increasing zeolite content in polymeric materials results in a higher rate of degradation due 
to the increased water uptake of the material (Kaali et al., 2010b). In this case, zeolite content 
above 1% showed significant degradation compared to an unfilled material. Therefore the 
only solution that can be applied for zeolite-polymer composites is the increase of the ion 
content. In case of composites, for microbial interaction diffusion is the main transport of the 
antimicrobial agent to the surface. It is usually governed by a concentration gradient, which 
forms between the material and the environment. In order to reach the equilibrium the 
agents are concentrated on the surface and if it is possible diffuse out. This process depends 
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on several factors such as the material, temperature, humidity etc. The problem with 
composites is that due to the diffusion, the release of the agent is slow and the antimicrobial 
effect might be limited. Therefore the bigger part of the research focuses on surface 
modification (i.e. plasma immersion)(Akamatsu et al., 2000, Huang et al., 2004, Zhang and 
Chu, 2008, Zhang, 2000) or coating of the materials. By the immersion techniques the 
antimicrobial agent can be incorporated onto the surface of the materials where they 
physically or chemically bond to the matrix. They remain at the interface region and can 
interact easier with the microorganisms than the antimicrobials in composite materials. In 
case of metallic coatings, the main challenge is the adhesion. Since polymeric and metallic 
surfaces are not compatible with each other, the development of coatings is based on the 
improvement of the adhesion between the polymer and metallic surface by different 
deposition techniques. The strength of adhesion between these two interfaces depends on 
the structure of the polymer, hydrophobicity and surface roughness. Some papers describe 
that the surface must be activated before the coating procedure which is usually done by 
plasma or neutral nuclear beam (Dowling et al., 2003, Dowling et al., 2001, Gray et al., 2005). 
The activation is followed by the deposition of the substrate. Dowling used magnetron to 
deposit silver coating and platinum. As a result, the thickness of the coating was estimated 
to 7-28nm and the coating passed the tape test. In case of physically bonded coatings, 
depending on application, the deposited layer may easily crack if the material is softer than 
the substrate. Most of the polymers are exposed to mechanical stress and during the use of a 
coated catheter, where bending of the device is common, the coating will sooner or later peel 
off the material. In contrast metallic coatings that are bonded chemically to functional 
groups of the polymer may show better elastic properties. Electroless deposition is a useful 
chemical process to coat polymer surfaces with metals without electric current. Studies have 
confirmed (Gray et al., 2005, Li et al., 2004)that the silver coating which is deposited by this 
technique bond chemically to the surface through carbonyl groups by forming Ag-O-C 
bond. The higher the amount of the carbonyl groups on the surface the better adhesion can 
be reached. Studying the antibacterial effect of these metallic antimicrobial coatings show 
promising results (MIC of Stapylococcusaureus 0,5-10mg/L). However, the investigation of 
cytotoxicity is a very important issue, since these surfaces may release a high amount of ions 
that may cause toxic reaction for the human body. The most common ways for detection of 
released metallic particles from polymers are atomic absorption spectroscopy (AAS) and 
ionic plasma coupled mass spectrometry (ICP-MS). These two techniques allow to monitor 
even very low concentrations of metallic ions. Since ICP has a lower detection limit it is used 
to monitor the ion release of both composites and coatings, AAS is applicable for metallic 
coatings and pure metals (Herting et al., 2007, Midander et al., 2007). 
Besides metallic coatings, research is focusingon variousnon-metallic coatings. One of the 
main interests in this field is based on multifunctional hydroxyapatite coatings that can be 
loaded with metallic particles or antibiotics (Brohede et al., 2009, Noda et al., 2009, 
Shimazaki et al., 2009). The application of this coating is mainly on hip joints and other 
metallic prostheses. Hydroxyapatite (HA) is a calcium apatite natural mineral that can be 
found in the body (teeth, bones) and therefore highly biocompatible. The role of 
hydroxyapatite as a coating is to ensure the tissue growth around the implant and decrease 
probability of rejection by the human body. Besides biocompatibility, if antibiotics or 
antimicrobial metallic particles are incorporated into the structure of HA the risk for 
infections and biofilm formation can be decreased. The trials showed that silver and 
antibiotics loaded HA coatings express superior antimicrobial properties on short term and 
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due to the slow release of the agent this characteristic can also be obtained on long term. 
Polymeric hydrogel coatings have also a great perspective. The main advantage of these 
materials is similar to hydroxyapatite, they are biologically inert, have good 
physicochemical properties and can be incorporated with either different antibiotics, or 
metallic nanoparticles to ensure their antimicrobial efficiency. The antimicrobial mechanism 
of hydrogels is the release of the agent to the environment. This release is governed by 
diffusion and influenced by the swelling and surface properties of the hydrogels. In 
principle this mechanism is the same as for antimicrobial-composites, however, the 
diffusion rate is much higher. Moreover, due to the chemical structure of the hydrogels, the 
release of antimicrobial agents is more even and pulsatile than in polymer composites. There 
is a wide variety of hydrogels which have different structures and release properties and 
therefore, for certain applications, these materials can be optimized to the antimicrobial 
agent. Besides the surface and release properties, hydrogels have to express good 
mechanical properties to be suitable for coatings. Based on a study, where the different 
hydrogel structures were tested, hydroxyethyl methacrylate and isopropylacrylamide based 
copolymers seemed to have the best properties (swelling, pulsatile release) for medical 
applications or drug delivery (Jones et al., 2008). Besides invasive materials, hydrogels are 
currently used for wound healing and clinical trials have confirmed their efficiency against 
infections. The antimicrobial and antiseptic properties depend also on the type of agent. So 
far silver nanoparticles incorporated into hydrogel coatings show the best antiseptic 
efficiency (Thomas et al., 2007, Dabbagh et al., 2008, Wu et al., 2009, Varaprasad et al.). 
However, due to the risk for silver toxicity (that may happen in case of high release rate) 
new antimicrobial agents are currently under development which are non-cytotoxic for 
human cells but has good efficiency against a variety of microorganisms (i.e. chitosan and 
bioactive antibodies)(Rojas et al., 2000, Yang et al., 2007) 
Besides synthetic materials, biological coatings or surface modifications are also reported 
and this field is growing extensively to exchange the currently used synthetic materials with 
more “human friendly” ones. In these studies biosurfactants produces by bacteria strains 
and bacteriophages as a coating to inhibit the biofilm formation on the surfaces (Goldman et 
al., 2009, Rivardo et al., 2009, Rodrigues et al., 2006) give the main frame of the research. The 
efficiency of these materials against biofilm formation was confirmed; in some cases 90% of 
growth reduction was observed. The mechanism that is responsible for inhibition of the 
biofilm is based on the enzymes that are produced by the bacteriophages. These enzymes 
are capable to destroy the EPS of biofilms. The eradication efficiency of antibiotics against 
urinary infective strains was also increased by the biosurfactants. In contrast,biosurfactants 
are not capable of destroying planktonic cells and inhibit only the growth of certain strains. 
Moreover, bacteriophages are only efficient against specific strains and therefore the 
solution might be the combined use of different surfactants and/or bacteriophages together. 
The idea of biological biofilm inhibitors and antibacterial agents has a great perspective, but 
further development and improvement is necessary in order to be used in medical 
applications. Peptides can be placed into this group as well. They are known as agents of the 
immune system and can be found in a wide variety of living organisms (i.e. bacteria, insects, 
human body etc.). These peptides are usually obtained from different sources as 
macrophages, neutrophils, epithelial cells etc. and exhibit high activity against 
microorganisms. Peptides are either chemically bonded or incorporated into the surface. The 
main advantage of chemically bonded peptides is that they express antimicrobial activity 
locally and in contrast to the synthetic coatings, where antimicrobial agents are released via 
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mechanical or chemical processes, these peptides remain on the surface of the material. 
Therefore, no release takes place resulting in a higher stability, lower toxicity and longer 
activity against microorganisms. The other application of antimicrobial peptides is a single 
or multilayer coating, where each peptide layer is followed by a biodegradable polymer 
layer. Due to the exposure to human environment these polymer layers degrade one by one 
and slowly release the antimicrobial peptide. The main advantages of the application of 
antimicrobial peptides compared to metallic or synthetic agents are the high 
biocompatibility, very low toxicity and well controlled release.  
6. Summary 
It has been shown that biofilm formation on polymeric medical devices is an issue and its 
effects on both of the human body and the device are negative. The attachment and 
formation mechanism of biofilm on surfaces is a very complex phenomenon. In general it is 
based on colloid chemistry and surface-surface interactions, where the adhesion strength 
depends on short and long range interactions (Van der Waals forces, hydrogen bonding, 
electrostatic interactions etc.). After the cell attachment, the biofilm formation begins by 
colonization and production of extracellular polymeric substance that embeds the 
microorganisms, ensures the adhesion to the surface and protects the biofilm from the outer 
environment and impacts. The extracellular polymer substance provides stability for the 
biofilm and protection against antimicrobial agents, which in turn causes initiation of the 
material degradation and induction of serious infections. The requirements for an implant 
or invasive materials are biocompatibility, non-toxicity, non-carcinogenicity and extreme 
stability, however, degradation of the material may occur due to the body response. The 
acceptance or rejection response of the human body depends highly on the size, shape and 
location of the material in the body. The sensitivity of the material to rejection and 
degradation is highly dependant on the chemical structure of the polymer. There are four 
major mechanisms that are responsible for degradation of biomedical materials: hydrolysis, 
oxidative, enzymatic and mechanical degradation. Enzymatic degradation can also be 
caused by biofilms. The mechanical degradation is referring to the swelling and friction 
under motion and pressure of the polymer and not directly influenced by the human body. 
The sterilization procedure also is one of the factors promoting the degradation of the 
devises. Due to gamma and electron sterilization, oxidative degradation of the polymer can 
occur resulting in a decrease of the molecular weight and degradation of additives. Low 
molecular weight compounds can leach out of the material causing toxic reactions. The 
sterilization of medical polymers with ethylene oxide does not lead to any significant 
degradation of the polymer structure, but the residues of ethylene oxide can cause toxic 
reactions.  
In order to prevent the negative effects of biofilms on the polymer surfaces and in the 
human body, the inhibition and control of biofilmformation is necessary. For this purpose 
antibiotics, silver- nanoparticles, salts and compounds are incorporated into the surface or 
the bulk of the material. Silver nanoparticles are also used as metallic coatings on the surface 
in physically or chemically bonded form. Clinical trials confirm that certain antibiotics and 
silver products are efficient as antiseptic agents and decrease the number of medical device 
associated infections in healthcare. The efficiency of silver is based on the silver ions 
released from the material, however, this is material and application dependant and not 
well controlled yet. A high concentration of silver released into the body can cause toxicity. 
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New coatings are under development for controlled and appropriately slow release of 
antibiotics or silver from the medical devices. Polymeric hydrogels can be one of the 
solutions for the controlled release due to their network structures, which allow a constant 
and sufficient release of the antimicrobial agents. Studies have shown that hydrogel 
dressings incorporated with antibiotics or nanoparticles assist the wound healing of the 
patients and decrease the risk for infections. Another recent development is extracellular 
polymeric substance that embeds the modification ofhydroxyapatite, a natural mineral that 
exists in the human body. Its pores can be filled with a variety of antimicrobial agents and 
provide a slow release mechanism. A new approach of research in inhibition of biofilm 
formation is the use of biological substances. Biological surfactants and bacteriophages are 
capable to inhibit the growth or destroy the biofilm. However, surfactants are not efficient 
against planktonic cells and not able to reduce the risk of infections caused by 
microorganisms. In addition bacteriophages can destroy only certain strains. The solution 
might be the combined use of different bacteriophages and surfactants to make these 
biological substances more universal against a variety of microorganisms. Their efficiency is 
confirmed, but since these solutions are newly introduced and developed, there is a big 
research potential in this field.     
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